Pharmafile Logo
Pharmafocus logo
Advanced Search

Teva

Showing 15 posts of 233 posts found.

mylan

Mylan pays $96.5 million to settle pay-for-delay case

February 7, 2017
Research and Development, Sales and Marketing Cephalon, Mylan, Teva, antitrust

Mylan has agreed to pay $96.5 million in order to settle an antitrust case. The case was related to the …

News
erez_vigodman

Teva’s CEO merry-go-round continues as Vigodman leaves

February 7, 2017
Manufacturing and Production, Medical Communications Teva, erez vigodman

Teva has maintained its habit of changing CEOs rather frequently, as Erez Vigodman has left by “mutual agreement”. He becomes …

News
teva_copy

Teva hit by patent blow upon top-selling MS drug

January 31, 2017
Manufacturing and Production Mylan, Teva, generic, multiple sclerosis

Teva endured a rough ride in 2016, seeing its market value sink progressively over the course of the year. It …

News
money-256281_960_720

Five most talked about mergers and acquisitions of 2016

January 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Bayer, Boehringer, Johnson & Johnson, Sanofi, Teva, acquisition, mergers, monsanto, pharma

2017 has kicked off with a bang – as Johnson & Johnson confirmed a $30 billion deal to takeover of …

Feature
teva

Teva agrees $225 million fee in antitrust case

January 27, 2017
Medical Communications Barr Laboratories, Teva, fine

Barr Laboratories, a subsidiary of Teva Pharmaceuticals, has settled an antitrust class action for $225 million. The case relates to …

News
lillycorporatehq

Lilly three strikes in three years not out in Teva patent challenge

January 13, 2017
Medical Communications, Sales and Marketing Eli Lilly, Teva, generics, lilly, patent

Eli Lilly has successfully won a major patent case against Teva Pharmaceuticals, with the case being decided at the US …

News
teva_copy

Teva hit with record fine $519 million corruption fine

December 23, 2016
Medical Communications Teva, corruption, fine

Teva Pharmaceuticals, the world’s largest generics company, has been hit with the largest criminal fine to come from the US …

News
dominos

Six generics companies hit by 20-state-strong lawsuit

December 16, 2016
Medical Communications Heritage, Mylan, Teva

Following hot on the heels of yesterday’s news that a former CEO and president of Heritage Pharmaceuticals had been charged …

News
sicorbio

Teva embroiled in internal bribery investigation

December 8, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, bribery

Israeli pharmaceutical firm Teva has confirmed it is embroiled in an ongoing internal investigation into allegations of bribery, after the …

News
sigurdur_olaffson_teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

Appointment
teva

CEO of Teva’s Generics Medicines Group steps down

December 6, 2016
Manufacturing and Production, Medical Communications Teva, generics

Sigurdur Olafsson will step down in the first quarter of 2017 as president and CEO of Teva’s Global Generic Medicines …

News

Teva to shut down Maltese plant, axe 210 jobs

November 30, 2016
Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva

Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …

News
teva_copy

Teva’s drug to replace chemotherapy in acute leukaemia

November 21, 2016
Medical Communications, Sales and Marketing Teva, chemotherapy, first line, first-line, leukaemia

Teva Pharmaceutical announced that their drug Trisenox has been given approval from the European Commission to become the first line …

News
teva_copy

Teva’s white elephant plant in Mexico inoperative

November 14, 2016
Manufacturing and Production Mexico, Rimsa, Teva

The Teva-Rimsa debacle continues to rumble on, with Teva’s plant in Mexico not producing any drugs for market. The plant …

News
sicorbio

Teva antihypertensive generic duo gets FDA thumbs up

November 7, 2016
Manufacturing and Production, Sales and Marketing Azor, FDA, Teva, Tribenzor

Teva has received the approval from the US Food and Drug Administration (FDA) for its generic hypertension treatments Tribenzor (olmesartan …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023